List of Tables
Table 1. Global Specialty Generics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Injectables
Table 3. Key Players of Oral
Table 4. Key Players of Others
Table 5. Global Specialty Generics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Specialty Generics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Specialty Generics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Specialty Generics Market Share by Region (2020-2025)
Table 9. Global Specialty Generics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Specialty Generics Market Share by Region (2026-2031)
Table 11. Specialty Generics Market Trends
Table 12. Specialty Generics Market Drivers
Table 13. Specialty Generics Market Challenges
Table 14. Specialty Generics Market Restraints
Table 15. Global Specialty Generics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Specialty Generics Market Share by Players (2020-2025)
Table 17. Global Top Specialty Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Generics as of 2024)
Table 18. Ranking of Global Top Specialty Generics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Specialty Generics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Specialty Generics, Headquarters and Area Served
Table 21. Global Key Players of Specialty Generics, Product and Application
Table 22. Global Key Players of Specialty Generics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Specialty Generics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Specialty Generics Revenue Market Share by Type (2020-2025)
Table 26. Global Specialty Generics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Specialty Generics Revenue Market Share by Type (2026-2031)
Table 28. Global Specialty Generics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Specialty Generics Revenue Market Share by Application (2020-2025)
Table 30. Global Specialty Generics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Specialty Generics Revenue Market Share by Application (2026-2031)
Table 32. North America Specialty Generics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Specialty Generics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Specialty Generics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Specialty Generics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Specialty Generics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Specialty Generics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Specialty Generics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Specialty Generics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Specialty Generics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Specialty Generics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Specialty Generics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Specialty Generics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Specialty Generics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Specialty Generics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Specialty Generics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Teva Pharmaceuticals Industries Company Details
Table 48. Teva Pharmaceuticals Industries Business Overview
Table 49. Teva Pharmaceuticals Industries Specialty Generics Product
Table 50. Teva Pharmaceuticals Industries Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 51. Teva Pharmaceuticals Industries Recent Development
Table 52. Akorn, Inc. Company Details
Table 53. Akorn, Inc. Business Overview
Table 54. Akorn, Inc. Specialty Generics Product
Table 55. Akorn, Inc. Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 56. Akorn, Inc. Recent Development
Table 57. Mylan N.V. Company Details
Table 58. Mylan N.V. Business Overview
Table 59. Mylan N.V. Specialty Generics Product
Table 60. Mylan N.V. Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 61. Mylan N.V. Recent Development
Table 62. Mallinckrodt Company Details
Table 63. Mallinckrodt Business Overview
Table 64. Mallinckrodt Specialty Generics Product
Table 65. Mallinckrodt Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 66. Mallinckrodt Recent Development
Table 67. Sandoz International GmbH Company Details
Table 68. Sandoz International GmbH Business Overview
Table 69. Sandoz International GmbH Specialty Generics Product
Table 70. Sandoz International GmbH Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 71. Sandoz International GmbH Recent Development
Table 72. Pfizer, Inc. Company Details
Table 73. Pfizer, Inc. Business Overview
Table 74. Pfizer, Inc. Specialty Generics Product
Table 75. Pfizer, Inc. Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 76. Pfizer, Inc. Recent Development
Table 77. Sun Pharmaceutical Industries Ltd. Company Details
Table 78. Sun Pharmaceutical Industries Ltd. Business Overview
Table 79. Sun Pharmaceutical Industries Ltd. Specialty Generics Product
Table 80. Sun Pharmaceutical Industries Ltd. Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 81. Sun Pharmaceutical Industries Ltd. Recent Development
Table 82. Valeant Pharmaceuticals Company Details
Table 83. Valeant Pharmaceuticals Business Overview
Table 84. Valeant Pharmaceuticals Specialty Generics Product
Table 85. Valeant Pharmaceuticals Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 86. Valeant Pharmaceuticals Recent Development
Table 87. Apotex Corp. Company Details
Table 88. Apotex Corp. Business Overview
Table 89. Apotex Corp. Specialty Generics Product
Table 90. Apotex Corp. Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 91. Apotex Corp. Recent Development
Table 92. Endo International plc. Company Details
Table 93. Endo International plc. Business Overview
Table 94. Endo International plc. Specialty Generics Product
Table 95. Endo International plc. Revenue in Specialty Generics Business (2020-2025) & (US$ Million)
Table 96. Endo International plc. Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Specialty Generics Picture
Figure 2. Global Specialty Generics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Specialty Generics Market Share by Type: 2024 VS 2031
Figure 4. Injectables Features
Figure 5. Oral Features
Figure 6. Others Features
Figure 7. Global Specialty Generics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Specialty Generics Market Share by Application: 2024 VS 2031
Figure 9. Retail Pharmacies Case Studies
Figure 10. Specialty Pharmacies Case Studies
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Specialty Generics Report Years Considered
Figure 13. Global Specialty Generics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Specialty Generics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Specialty Generics Market Share by Region: 2024 VS 2031
Figure 16. Global Specialty Generics Market Share by Players in 2024
Figure 17. Global Top Specialty Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Generics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Specialty Generics Revenue in 2024
Figure 19. North America Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Specialty Generics Market Share by Country (2020-2031)
Figure 21. United States Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Specialty Generics Market Share by Country (2020-2031)
Figure 25. Germany Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Specialty Generics Market Share by Region (2020-2031)
Figure 33. China Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Specialty Generics Market Share by Country (2020-2031)
Figure 41. Mexico Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Specialty Generics Market Share by Country (2020-2031)
Figure 45. Turkey Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Specialty Generics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Teva Pharmaceuticals Industries Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 49. Akorn, Inc. Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 50. Mylan N.V. Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 51. Mallinckrodt Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 52. Sandoz International GmbH Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 53. Pfizer, Inc. Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 54. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 55. Valeant Pharmaceuticals Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 56. Apotex Corp. Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 57. Endo International plc. Revenue Growth Rate in Specialty Generics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
